Chr. Hansen
Search results
The combination of Novozymes and Chr. Hansen is now successfully completed. Novonesis is a world-leading biosolutions partner for better business, healthier lives, and a healthier planet.
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Novozymes brings the biology and science to the table. We know that many of the answers which the world needs can be found in its smallest components: enzymes, microorganisms and precision proteins. Our biotechnology can achieve the unimagined.
Novozymes (China) Investment Co Ltd. Call us at our number: 8610 62987888 Write or visit our office: No. 14, Xinxi Road, Shangdi Zone, Beijiing 100085, China
Find the right product for you. Use the filters below to find a biosolution that suits your needs. Select industry. Select application. Select industry to explore products.
Novozymes is the world leader in biosolutions. We use the power of biotech to help our customers grow their businesses while preserving the planet’s resources and enabling better lives. Our purpose is at the heart of who we are and the guiding principle for the way we do business.
Novozymes was formed in 2000 when Novo Nordisk split into three companies: Novo Nordisk A/S, Novozymes A/S and Novo A/S. Novozymes was the world leader in biological solutions with...
The Novozymes Report 2022
In 2024 Chr. Hansen and Novozymes joined forces to form Novonesis. We are 10,000 people worldwide whose expertise spans more than 30 different industries. All around the world our biosolutions already create value for thousands of customers and benefit the planet.
A brighter future with biotech. 2021 was a year of many things – overcoming, inspiring, investing, delivering, and learning. Despite continuing uncertainties throughout the year, our employees showed resilience, commitment, and adaptability, helping Novozymes to achieve even greater impact and strong results for the year.
